PUBLISHER: DataM Intelligence | PRODUCT CODE: 1083000
PUBLISHER: DataM Intelligence | PRODUCT CODE: 1083000
Global Pediatric Nebulizer Market - 2022-2029
Market - Overview
The global pediatric nebulizer market size was valued US$ XX million in 2021 and is estimated to reach US$ XX million by 2029, growing at a CAGR of XX % during the forecast period (2022-2029).
A nebulizer is a machine that uses electricity to transform liquid medication into a mist that may be inhaled directly into the lungs via a face mask or mouthpiece. It is an asthma therapy option for children aged 6 and under who use a mask and children aged 6 and up who use a mouthpiece.
Market Dynamics
Innovation in the Pediatric Nebulizers is expected to drive market growth.
FOX vibrating mesh nebulizer was developed by Vectura Group Ltd, a British pharmaceuticals company based in Chippenham, England. It is a small, handheld, breath-activated, battery-powered inhalation system suitable for delivering small molecules and biologics formulated as solutions or nano-suspensions. More holes (1000-15,600) in more recently produced vibrating mesh nebulizers allow smaller droplet sizes and faster flow rates. Furthermore, new Surface Acoustic Wave (SAW) nebulizers make aerosols by generating short-frequency sound waves that flow along the surface of a liquid. They have many advantages as vibrating mesh nebulizers, but they also generate less clogging, making them ideal for nebulizing monoclonal antibodies and peptides. Thus, the market is expected to drive in the forecast period from the above statements.
Restraint:
Higher costs, longer set-up and delivery time, decreased portability, variable nebulizer performance, and the need for a source of compressed air or oxygen are some of the factors the market is expected to get hampered in the forecast period.
COVID-19 Impact Analysis
COVID-19 pandemic has positively impacted the healthcare industry with increased demand for pediatric nebulizers, which is likely to drive the market during the forecast period. COVID- 19 infections can produce various symptoms, but they most commonly affect the respiratory system. These symptoms might range from a sore throat to cough to more serious lung issues. Reactive airway disease, which causes wheezing and shortness of breath, or severe respiratory compromise, which can be caused by acute respiratory distress syndrome (ARDS) and necessitates mechanical ventilation, are more severe symptoms. The start of severe respiratory symptoms can happen throughout the disease, and it often happens quickly. In contrast, the pandemic interrupts the supply chain and process. Many companies will vary to other geographic regions to ensure that products remain available and protect their supply chain.
Segment Analysis
Jet Nebulizer segment is expected to hold the largest market share in pediatric nebulizer market
The jet nebulizer segment is expected to dominate in 2021. The segment benefits because effective use requires only simple tidal breathing, and dose modification and compounding are possible. Traditionally, nebulization devices based on jet technology have been employed for delivering aerosolized drugs. The clinically established technological advantages of jet devices and their considerably reduced costs have aided in their global adoption and demand. This, together with the rise of domestic manufacturers offering novel and low-cost gadgets in this area, is propelling the industry's growth, particularly in emerging markets.
Geographical Analysis
North America region holds the largest market share in the global pediatric nebulizer market
In 2021, North America accounted for the highest revenue share. The increasing prevalence of asthma, technological advancement in the devices, rising geriatric population, well-established infrastructure, adequate reimbursement policies for the devices and product launches by the key players are some factors the market is expected to boost in the forecast period. For instance, according to the American College of Allergy, Asthma & Immunology, 8.3% of Americans have asthma. Of these 26.5 million, 20.4 million are adults, and 6.1 million are children. Asthma prevalence is higher in children (9.4 percent) than in adults (7.7 percent) and higher in females (9.2 percent) than males (7.0 percent). Moreover, patients with asthma reported 11 million visits to a doctor's office and 1.7 million visits to hospital outpatient departments, and the estimated economic cost of asthma is $56 billion annually.
Additionally, B.Well launched the PRO-115 compressor nebulizer in June 2021, a fun-looking respiratory gadget in the shape of a toy. The manufacturer's product is very efficient and meets the European nebulizer standard EN13544. Thus, the North American region is expected to hold the largest market share in the forecast period from the above statements.
Competitive Landscape
Major key players in the pediatric nebulizer market are OMRON Healthcare, Inc., B.Well Swiss, Trudell Medical International, Little Doctor International, Jiangsu Folee Medical Equipment CO., LTD, Fazzini Srl, Norditalia Group S.r.l., Microlife Corporation, Fahl Medizintechnik-Vertrieb, GF Health Products Inc.
Omron Healthcare, Inc.:
Overview:
Omron Healthcare, Inc. is a leading manufacturer and distributor of wellness products. The company is guided by its philosophy of accuracy and accessibility that allows them to extend into a wide variety of fitness monitors, electrotherapy pain relief products and respiratory devices. Omron products provide accurate health information that supports positive lifestyle changes and can be shared with friends, family and other health professionals.
Product Portfolio:
Portable MicroAir Battery-Operated Nebulizer: The MicroAir U100 Nebulizer is a small, handheld battery-operated nebulizer. It uses unique, vibrating mesh technology with fast misting to help deliver the optimal amount of medication. Plus, it operates almost silently (less than a whisper at 23 dBA*) and can be held in any position with 360° operation-laying down or sitting up.
Why Purchase the Report?
Visualize the composition of the pediatric nebulizer market segmentation by type, portability, disease type, end user, and region highlighting the key commercial assets and players.
Identify commercial opportunities in pediatric nebulizer market by analyzing trends and co-development deals.
Excel data sheet with thousands of data points of pediatric nebulizer market- level 4/5 segmentation.
PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
Product mapping in excel for the key product of all major market players
The global pediatric nebulizer market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.
Target Audience
Service Providers/ Buyers
Industry Investors/Investment Bankers
Education & Research Institutes
Research Professionals
Emerging Companies
Manufacturers
Table of Contents
1. Methodology and Scope
- 1.1. Research Methodology
- 1.2. Research Objective and Scope of the Report
2. Market Definition and Overview
3. Executive Summary
- 3.1. Market Snippet by Type
- 3.2. Market Snippet by Portability
- 3.3. Market Snippet by Disease Type
- 3.4. Market Snippet by End user
- 3.5. Market Snippet by Region
4. Market Dynamics
- 4.1. Market Impacting Factors
- 4.1.1. Drivers
- 4.1.1.1. Innovation in the Pediatric Nebulizers is expected to drive market growth.
- 4.1.2. Restraints:
- 4.1.2.1. Higher costs of the Pediatric Nebulizer are expected to hamper in the forecast period.
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis
- 4.1.1. Drivers
5. Industry Analysis
- 5.1. Supply Chain Analysis
- 5.2. Pricing Analysis
- 5.3. Unmet Needs
6. COVID-19 Analysis
- 6.1. Analysis of Covid-19 on the Market
- 6.1.1. Before COVID-19 Market Scenario
- 6.1.2. Present COVID-19 Market Scenario
- 6.1.3. After COVID-19 or Future Scenario
- 6.2. Pricing Dynamics Amid Covid-19
- 6.3. Demand-Supply Spectrum
- 6.4. Government Initiatives Related to the Market During Pandemic
- 6.5. Manufacturers Strategic Initiatives
- 6.6. Conclusion
7. By Type
- 7.1. Introduction
- 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
- 7.1.2. Market Attractiveness Index, By Type Segment
- 7.2. Jet Nebulizer*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
- 7.3. Ultrasonic Nebulizer
- 7.4. Mesh Nebulizer
- 7.5. Electronic Nebulizer
- 7.6. Others
8. By Probability
- 8.1. Introduction
- 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Probability
- 8.1.2. Market Attractiveness Index, By Probability Segment
- 8.2. Portable*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
- 8.3. Tabletop
9. By Disease Type
- 9.1. Introduction
- 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Type
- 9.1.2. Market Attractiveness Index, By Disease Type Segment
- 9.2. Asthma*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
- 9.3. Cystic Fibrosis
- 9.4. Pneumonia
- 9.5. Others
10. By End user
- 10.1. Introduction
- 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
- 10.1.2. Market Attractiveness Index, By End user Segment
- 10.2. Hospital*
- 10.2.1. Introduction
- 10.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
- 10.3. Clinics
- 10.4. Homecare
- 10.5. Others
11. By Region
- 11.1. Introduction
- 11.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
- 11.1.2. Market Attractiveness Index, By Region
- 11.2. North America
- 11.2.1. Introduction
- 11.2.2. Key Region-Specific Dynamics
- 11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
- 11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Portability
- 11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Type
- 11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
- 11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
- 11.2.7.1. U.S.
- 11.2.7.2. Canada
- 11.2.7.3. Mexico
- 11.3. Europe
- 11.3.1. Introduction
- 11.3.2. Key Region-Specific Dynamics
- 11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
- 11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Portability
- 11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Type
- 11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
- 11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
- 11.3.7.1. Germany
- 11.3.7.2. U.K.
- 11.3.7.3. France
- 11.3.7.4. Italy
- 11.3.7.5. Spain
- 11.3.7.6. Rest of Europe
- 11.4. South America
- 11.4.1. Introduction
- 11.4.2. Key Region-Specific Dynamics
- 11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
- 11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Portability
- 11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Type
- 11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
- 11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
- 11.4.7.1. Brazil
- 11.4.7.2. Argentina
- 11.4.7.3. Rest of South America
- 11.5. Asia Pacific
- 11.5.1. Introduction
- 11.5.2. Key Region-Specific Dynamics
- 11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
- 11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Portability
- 11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Type
- 11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
- 11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
- 11.5.7.1. China
- 11.5.7.2. India
- 11.5.7.3. Japan
- 11.5.7.4. Australia
- 11.5.7.5. Rest of Asia Pacific
- 11.6. Middle East and Africa
- 11.6.1. Introduction
- 11.6.2. Key Region-Specific Dynamics
- 11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
- 11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Portability
- 11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Type
- 11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
12. Competitive Landscape
- 12.1. Key Developments and Strategies
- 12.2. Company Share Analysis
- 12.3. Product Benchmarking
- 12.4. List of Key Companies to Watch
13. Company Profiles
- 13.1. OMRON Healthcare, Inc.*
- 13.1.1. Company Overview
- 13.1.2. Product Portfolio and Description
- 13.1.3. Key Highlights
- 13.1.4. Financial Overview
- 13.2. B.Well Swiss
- 13.3. Trudell Medical International
- 13.4. Little Doctor International
- 13.5. Jiangsu Folee Medical Equipment CO., LTD
- 13.6. Fazzini Srl
- 13.7. Norditalia Group S.r.l.
- 13.8. Microlife Corporation
- 13.9. Fahl Medizintechnik-Vertrieb
- 13.10. GF Health Products Inc.
LIST NOT EXHAUSTIVE
14. Global Pediatric Nebulizer Market - DataM
- 14.1. Appendix
- 14.2. About Us and Applications
- 14.3. Contact Us
